EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Repurposing cadazolid as a CBLB-dependent non-PROTAC FAK degrader to suppress lung adenocarcinoma and restore EGFR-TKI sensitivity

Yihua Zhang, Yuna Shao, Liying Zhang, Shihang Ren, Di Lu, Huiling Zhang, Xinyu Qian, Yuling Chen, Yang Yang, Jianjie Zhu, Yuanyuan Zeng, Shengjie Wang und 2 weitere

Journal of Pharmaceutical Analysis · 2026-11 · 101839

DOI: 10.1016/j.jpha.2026.101839 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-11. Verfasst von Yihua Zhang und 13 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhang, Y., Shao, Y., Zhang, L., Ren, S., Lu, D., Zhang, H., Qian, X., Chen, Y., Yang, Y., Zhu, J., Zeng, Y., Wang, S., Yan, Z., & Liu, Z. (2026). Repurposing cadazolid as a CBLB-dependent non-PROTAC FAK degrader to suppress lung adenocarcinoma and restore EGFR-TKI sensitivity. Journal of Pharmaceutical Analysis, 101839. https://doi.org/10.1016/j.jpha.2026.101839

Vancouver

Zhang Y, Shao Y, Zhang L, Ren S, Lu D, Zhang H, et al. Repurposing cadazolid as a CBLB-dependent non-PROTAC FAK degrader to suppress lung adenocarcinoma and restore EGFR-TKI sensitivity. Journal of Pharmaceutical Analysis. 2026:101839. doi:10.1016/j.jpha.2026.101839

BibTeX
@article{Zhang2026,
  author = {Zhang, Yihua and Shao, Yuna and Zhang, Liying and Ren, Shihang and Lu, Di and Zhang, Huiling and Qian, Xinyu and Chen, Yuling and Yang, Yang and Zhu, Jianjie and Zeng, Yuanyuan and Wang, Shengjie and Yan, Zhaowei and Liu, Zeyi},
  title = {Repurposing cadazolid as a CBLB-dependent non-PROTAC FAK degrader to suppress lung adenocarcinoma and restore EGFR-TKI sensitivity},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  pages = {101839},
  doi = {10.1016/j.jpha.2026.101839}
}
Kostenlos starten →